Heart failure remains a major public health disease with high morbidity and mortality, and it is the leading cause of hospitalizations in older patients (>65 years). The role of sodium-glucose…
Renal transplant recipients are at higher risk for development of valvular heart disease, including mitral regurgitation. The management of severe mitral regurgitation among renal transplant recipients poses a challenging dilemma….
Every year, it is estimated that over 1 million cardiac catheterization procedures are performed in the United States. Traditionally, vascular access for cardiac catheterization procedures was obtained by femoral artery…
Peripheral artery disease (PAD) remains a major cause of morbidity and future cardiovascular events despite advancement in the surgical interventions and optimal medical therapy. The aim of our study is…
Highlights • A new integrated risk tool combines clinical and polygenic risk scores. • Prediction is significantly enhanced in multiple ethnicities and ancestries. • Ethnicities include Black and White, ancestries…
In the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT), tafamidis significantly reduced mortality and cardiovascular (CV)-related hospitalizations compared with placebo in patients with transthyretin amyloid cardiomyopathy (ATTR-CM). This analysis aimed…
Highlights • Many patients fail to undergo intervention transcatheter mitral valve intervention. • Even at a large, tertiary center, 62% of referred patients are treated medically. • Exclusion reasons include…
Chronic pressure-overload induces right ventricular (RV) adaptation to maintain RV–pulmonary arterial (PA) coupling. RV remodeling is frequently associated with secondary tricuspid regurgitation (TR) which may accelerate uncoupling. Our aim is…
The ECG findings during sudden collapse (syncope or sudden death) in severe aortic stenosis (AS) are not well defined. We conducted a comprehensive review of the literature for ECG data…
The prognostic impact of preexisting atrial fibrillation or flutter (AF) in low-risk patients with severe aortic stenosis treated with transcatheter (TAVR) or surgical aortic valve replacement (SAVR) remains unknown. In…
